The efficacy of Phoenix dactylifera L. sap for the treatment of lung injury in a murine model of pulmonary fibrosis

S. BAHRI (Tunis, Tunisia), R. Abdennabi (Sfax, Tunisia), R. Ben Ali (Tunis, Tunisia), M. Mlika (Tunis, Tunisia), N. Gharsallah (Athens, Greece), K. Ayed (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)

Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. BAHRI (Tunis, Tunisia), R. Abdennabi (Sfax, Tunisia), R. Ben Ali (Tunis, Tunisia), M. Mlika (Tunis, Tunisia), N. Gharsallah (Athens, Greece), K. Ayed (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia). The efficacy of Phoenix dactylifera L. sap for the treatment of lung injury in a murine model of pulmonary fibrosis. 3718

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Nigella sativa fixed oil, attenuates bleomycin-induced pulmonary fibrosis in a rat model
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018


Does Rosemary leaves extract can attenuate lung injury in experimental pulmonary fibrosis in rats?
Source: International Congress 2016 – ILD pathogenesis
Year: 2016


Coix lacryma-jobi L. var. ma-yuen Stapf sprout extract (CLSE) protects against cigarette smoke-induced lung inflammation in rats
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019


Anti-fibrotic and antioxidant effects of Ailanthus altissima wood aqueous extract against bleomycin-induced lung fibrosis in rat
Source: International Congress 2017 – Therapeutic approaches in lung disease
Year: 2017


Glycine efficacy for prevention or treatment on LPS-acute lung injury in mice
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


Transgenic mice expressing a surfactant protein-B-urokinase-fusion protein in the distal respiratory epithelium show an attenuated fibrotic response to bleomycin-induced lung injury
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005


Effect of Pistacia lentiscus oil on inflammatory infiltrate in experimental lung fibrosis in rats
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010


Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011

Effect of Nintedanib in a rat model of bleomycin-induced lung fibrosis: a transcriptome analysis
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


Effect of thymus vulgaris leaf extract on bleomycin induced oxidative stress and lung fibrosis in rats
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021

LSC Abstract – A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
Source: International Congress 2016 – Molecular immunology of the lung
Year: 2016

Sustained PAP-reduction and tissue cGMP-restoration without systemic NO-generation by aerosolized PAPA-NONOate in an isolated lung model of acute lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 561s
Year: 2004

KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015

New approach to the treatment of bleomycin-induced lung fibrosis using pulmonary surfactant as pirfenidone carrier into the lung
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015

Interferon-γ pretreated human MSC show improved efficiency in humanized mice model of pulmonary fibrosis
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016

Effect of intratracheal administration of adipose-derived stromal cells on bleomycin-induced lung injury in a rat model
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015


Time course of lung parenchyma remodelling in different models of extrapulmonary acute lung injury
Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies
Year: 2008

Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation versus fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006

FGF-9 overexpression prevents pleural fibrosis induced by intra-pleural adenovirus injection in mice
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015


Chronic lung disease in CF mouse models, role of macrophages, treatment with azithromycin
Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease
Year: 2009